T. Rowe Price Investment Management, Inc.
Position in CRNX — Crinetics Pharmaceuticals, Inc.
CIK 1897612
BALTIMORE, MD
Position in CRNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$70,483,391
+$67,731,309 QoQ
Shares Held
1,940,622
+3182.5% QoQ
Ownership
1.84%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CRNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026T. Rowe Price Investment Management, Inc. holds $9,767,505,959 across 47 Biotechnology names. CRNX ranks #21 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,193,324 | $1,718,315,111 | |
| 2 | CYTK |
Cytokinetics Inc
|
17,523,840 | $1,154,996,294 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
10,300,984 | $867,033,823 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
12,126,017 | $704,642,847 | |
| 5 | DYN |
Dyne Therapeutics, Inc.
|
30,785,801 | $558,146,572 | |
| 6 | BNTX |
BioNTech SE
|
5,856,073 | $520,487,768 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
6,159,027 | $462,481,337 | |
| 8 | KYMR |
Kymera Therapeutics, Inc.
|
5,464,997 | $455,179,600 |
All Filings in CRNX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $70,483,391 | 1,940,622 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,752,082 | 59,121 | Shares | Sole | 2026-02-19 | |
| 2025-09-30 | $2,523,323 | 60,584 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $20,597,106 | 716,172 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $23,117,948 | 689,265 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $51,277,356 | 1,002,882 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $54,601,985 | 1,068,532 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $60,341,535 | 1,347,210 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $124,267,864 | 2,654,729 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $86,014,400 | 2,417,493 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $48,794,180 | 1,640,692 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,371,370 | 964,005 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,925,666 | 929,369 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||